Allurion Technologies Inc (ALUR)
2.30
+0.10
(+4.55%)
USD |
NYSE |
May 03, 16:00
2.33
+0.03
(+1.30%)
After-Hours: 20:00
Allurion Technologies Cash from Financing (TTM): 95.99M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 95.99M |
| September 30, 2023 | 131.03M |
| June 30, 2023 | 41.94M |
| Date | Value |
|---|---|
| March 31, 2023 | 42.24M |
| December 31, 2022 | 30.54M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
30.54M
Minimum
Dec 2022
131.03M
Maximum
Sep 2023
68.35M
Average
42.24M
Median
Mar 2023
Cash from Financing (TTM) Benchmarks
| Outset Medical Inc | 43.65M |
| Paragon 28 Inc | 128.65M |
| Perspective Therapeutics Inc | 0.785M |
| Xtant Medical Holdings Inc | 19.69M |
| Asensus Surgical Inc | 9.626M |